Abstract
Nanotechnology’s applicability in medicine, specifically drug delivery, is expected to grow substantially. Because of their ability to overcome drug transportation constraints, nanotechnology in drug transport systems could be a possible technique for overcoming traditional drug delivery. A targeted Drug Delivery system can enhance the transport and nearby awareness of drugs. Targeted transport processes for most cancer therapeutics have proven a steep upward push over the beyond few decades. However, in comparison to the plethora of hit pre-scientific studies, the best passively centered Nanocarriers (NCs) had been accredited for scientific use and none of the actively centered NCs have superior beyond scientific trials. Herein, we overview the principles at the back of centered transport processes to decide the ability motives for restrained scientific translation and success. We advocate standards and concerns that ought to be taken into account for the improvement of novel actively centered NCs. We additionally spotlight the possible instructions for the improvement of a hit tumor and concentrated on strategies.
Keywords
References
- 88. Li, X., Wang, C., Tan, H., Cheng, L., Liu, G., Yang, Y., et al. (2016). Gold nanoparticles-based SPECT/CT imaging probe targeting for vulnerable atherosclerosis plaques. Biomaterials 108, 71–80.
- 89. Fan J, Fang G, Wang X, Zeng F, Xiang Y, Wu S. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles. Nanotechnology. 2011;22:455102.
- 90. Bimbo LM. Biocampatability and Biofunctionalization of Mesoporous Silicon Particles. Finland: Divi of Pharmaceutical Technology, University of Helsiniki; 2012.
- 91. Shah A, Saima A, Jan N, Naeem A, Iftikhar F. Nanocarriers for targeted drug delivery,J Drug Deliv Sci Technol, 62,2021, 1773-2247
Abstract
Nanotechnology’s applicability in medicine, specifically drug delivery, is expected to grow substantially. Because of their ability to overcome drug transportation constraints, nanotechnology in drug transport systems could be a possible technique for overcoming traditional drug delivery. A targeted Drug Delivery system can enhance the transport and nearby awareness of drugs. Targeted transport processes for most cancer therapeutics have proven a steep upward push over the beyond few decades. However, in comparison to the plethora of hit pre-scientific studies, the best passively centered Nanocarriers (NCs) had been accredited for scientific use and none of the actively centered NCs have superior beyond scientific trials. Herein, we overview the principles at the back of centered transport processes to decide the ability motives for restrained scientific translation and success. We advocate standards and concerns that ought to be taken into account for the improvement of novel actively centered NCs. We additionally spotlight the possible instructions for the improvement of a hit tumor and concentrated on strategies.
Keywords
References
- 88. Li, X., Wang, C., Tan, H., Cheng, L., Liu, G., Yang, Y., et al. (2016). Gold nanoparticles-based SPECT/CT imaging probe targeting for vulnerable atherosclerosis plaques. Biomaterials 108, 71–80.
- 89. Fan J, Fang G, Wang X, Zeng F, Xiang Y, Wu S. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles. Nanotechnology. 2011;22:455102.
- 90. Bimbo LM. Biocampatability and Biofunctionalization of Mesoporous Silicon Particles. Finland: Divi of Pharmaceutical Technology, University of Helsiniki; 2012.
- 91. Shah A, Saima A, Jan N, Naeem A, Iftikhar F. Nanocarriers for targeted drug delivery,J Drug Deliv Sci Technol, 62,2021, 1773-2247
Details
| Primary Language | English |
|---|---|
| Subjects | Pharmacology and Pharmaceutical Sciences |
| Journal Section | Review Articles |
| Authors | |
| Publication Date | December 1, 2022 |
| Acceptance Date | June 10, 2022 |
| Published in Issue | Year 2022 Volume: 42 Issue: 4 |